E, B., Y, X., DC, M., HS, C., XB, S., N, C., . . . JM, L. (2012). In vitro analysis of ovarian cancer response to cisplatin, carboplatin, and paclitaxel identifies common pathways that are also associated with overall patient survival. British journal of cancer, 106(12), 1967. https://doi.org/10.1038/bjc.2012.207
Chicago Style (17th ed.) CitationE, Bicaku, et al. "In Vitro Analysis of Ovarian Cancer Response to Cisplatin, Carboplatin, and Paclitaxel Identifies Common Pathways That Are Also Associated with Overall Patient Survival." British Journal of Cancer 106, no. 12 (2012): 1967. https://doi.org/10.1038/bjc.2012.207.
MLA (9th ed.) CitationE, Bicaku, et al. "In Vitro Analysis of Ovarian Cancer Response to Cisplatin, Carboplatin, and Paclitaxel Identifies Common Pathways That Are Also Associated with Overall Patient Survival." British Journal of Cancer, vol. 106, no. 12, 2012, p. 1967, https://doi.org/10.1038/bjc.2012.207.